Proactive Diagnostics' has developed a state-of-the-art novel technology, combining multiplexing capabilities (simultaneous testing for several proteins, nucleic acids, and small molecules), with central lab sensitivity and specificity, in one affordable and quick test, easily performed on a finger-prick blood sample or other bodily fluids, wherever needed.
In the coming years, artificial intelligence and machine learning will be increasingly utilized to generate key and personalized medical insights that will aid in the screening, early detection, prevention, and prognosis, of a long line of illnesses and conditions, reduce public healthcare expenditure, and allow to save and improve many lives.
Together with several partners and investors, we have performed a range of feasibility studies, proving our technology’s applicability for different uses (cardiovascular disease biomarkers, autoimmunity antibodies, infectious diseases, inflammation cytokines, and more). Our platform has all the necessary traits to become a core part of the imminent revolution of digital health profiling and personalized care and well-being. We are open to exploring collaborations with strategic partners looking to utilize our technology's unique capabilities, to offer a line of molecular and immunoassay solutions at various points of need.
The COVID-19 Crisis
In the year 2020, humanity has come to face one of the gravest epidemiological crises in its history, which has nearly paralyzed the global economy and continue to threaten to undermine sociopolitical structures everywhere. The COVID-19 pandemic has crystallized the need for a scalable, rapid, and precise point-of-care diagnostics solution!
Pathogenic outbreaks, such as the one brought about by the novel Coronavirus (SARS-Cov-2), and inevitable future ones, should not be detrimental occurrences. It is within our ability to contain and manage them intelligently, well before they grow into widely socially disruptive events. Proactive Diagnostics' technology has all the necessary traits to meet the challenge of enabling effective, wide-scale diagnostics, and aid in keeping pathogenic outbreaks at bay.